277 related articles for article (PubMed ID: 15758557)
1. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
Saiki Y; Ishihara T; Ikekubo K; Mori T
Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
Ochi Y; Hamazu M; Kajita Y; Nagata A
Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
[TBL] [Abstract][Full Text] [Related]
4. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
[TBL] [Abstract][Full Text] [Related]
5. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
[TBL] [Abstract][Full Text] [Related]
6. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987
[TBL] [Abstract][Full Text] [Related]
7. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
[TBL] [Abstract][Full Text] [Related]
8. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
Uno C; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):193-205. PubMed ID: 2899523
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TSH binding to chicken thyroid by some cases of LATS (long acting thyroid stimulator).
Nakajima Y; Ishida M; Kajita Y; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
Endocrinol Jpn; 1986 Jun; 33(3):375-83. PubMed ID: 3019653
[TBL] [Abstract][Full Text] [Related]
12. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
Davies TF; Platzer M
Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of thyroid-stimulating antibody-stimulated cyclic adenosine monophosphate response by polyethylene glycol, polyvinyl alcohol, and dextran; highly sensitive porcine thyroid cell thyroid-stimulating antibody assay.
Yamashiro K; Takasu N; Kouki T; Inui T; Ochi Y; Kajita Y; Sato Y; Nagata A
Thyroid; 1999 Mar; 9(3):263-71. PubMed ID: 10211603
[TBL] [Abstract][Full Text] [Related]
14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
15. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A
Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
[TBL] [Abstract][Full Text] [Related]
16. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J
Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
[TBL] [Abstract][Full Text] [Related]
17. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
18. Sensitive assay to detect thyroid stimulating antibody (TSAb) in the presence of thyroid stimulation blocking antibody (TSBAb) in serum.
Ochi Y; Yamashiro K; Takasu N; Kajita Y; Sato Y; Nagata A
Horm Metab Res; 2001 Feb; 33(2):115-20. PubMed ID: 11294493
[TBL] [Abstract][Full Text] [Related]
19. [The effects of TSH, cholera toxin and Graves' IgG on cAMP production in cultured human thyroid adenoma cells in monolayer].
Tsuboi K
Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):541-53. PubMed ID: 2862066
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
